2002The Chinese Journal of Clinical PharmacologyRequires access

Study on the Pharmacokinetics and Bioavailability of Loratadine Tablets in Healthy Volenteers

Zhong Guo

Open publisher page 0 citations

Abstract

OBJECTIVE: To study the pharmacokinetics and bioequivdent ofloratadine in healthy Volunteers. METHODS:A single oral dose 40mg loratadine ofreference or test preparations was given to healthy male volunteers according toan open randomized crossover study.The plasma concentrations of loratadine weredetermined by a RP HPLC method. The pharmacokinetic parameters and biovailabilityof test preparation were compared with reference preparation. RESULTS: The mainpharmacokinetic parameters of the reference and the test preparation were as follows:Cmax were 34.9±16.6μg.L-1and 33.5±l7.4μg.L-1; tmax were 0.76±0.24h and 0.75±0.26h;t(1/2)were l.63±0.48h and l.73±0.49h;AUC0-tn were 53.7±25.9μg.h.L-1 and48.8±2l.0μg.h.L-1; AUC0→∞were 58.5±28.0μg.h.L-1 and 54.6±23.8μg.h.L-1, Therelative bioavailability of reference to test preparation was 94.5 %±l4.5 %.CONCLUSION: The results of statistics analysis showed that the referencepreparation and the test preparation were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE: To study the pharmacokinetics and bioequivdent ofloratadine in healthy Volunteers. METHODS:A single oral dose 40mg loratadine ofreference or test preparations was given to healthy male volunteers according toan open randomized crossover study.The plasma concentrations of loratadine weredetermined by a RP HPLC method. The pharmacokinetic parameters and biovailabilityof test preparation were compared with reference preparation. RESULTS: The mainpharmacokinetic parameters of the reference and the test preparation were as follows:Cmax were 34.9±16.6μg.L-1and 33.5±l7.4μg.L-1; tmax were 0.76±0.24h and 0.75±0.26h;t(1/2)were l.63±0.48h and l.73±0.49h;AUC0-tn were 53.7±25.9μg.h.L-1 and48.8±2l.0μg.h.L-1; AUC0→∞were 58.5±28.0μg.h.L-1 and 54.6±23.8μg.h.L-1, Therelative bioavailability of reference to test preparation was 94.5 %±l4.5 %.CONCLUSION: The results of statistics analysis showed that the referencepreparation and the test preparation were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To study the pharmacokinetics and bioequivdent ofloratadine in healthy Volunteers. METHODS:A single oral dose 40mg loratadine ofreference or test preparations was given to healthy male volunteers according toan open randomized crossover study.The plasma concentrations of loratadine weredetermined by a RP HPLC method. The pharmacokinetic parameters and biovailabilityof test preparation were compared with reference preparation. RESULTS: The mainpharmacokinetic parameters of the reference and the test preparation were as follows:Cmax were 34.9±16.6μg.L-1and 33.5±l7.4μg.L-1; tmax were 0.76±0.24h and 0.75±0.26h;t(1/2)were l.63±0.48h and l.73±0.49h;AUC0-tn were 53.7±25.9μg.h.L-1 and48.8±2l.0μg.h.L-1; AUC0→∞were 58.5±28.0μg.h.L-1 and 54.6±23.8μg.h.L-1, Therelative bioavailability of reference to test preparation was 94.5 %±l4.5 %.CONCLUSION: The results of statistics analysis showed that the referencepreparation and the test preparation were bioequivalent.

Key concepts: Bioequivalence, Loratadine, Pharmacokinetics, Bioavailability, Cmax, Crossover study, Pharmacology, Test preparation

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the Pharmacokinetics and Bioavailability of Loratadine Tablets in Healthy Volenteers — Research Paper | ScholarLens